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Targeting patients for multimorbid care management interventions requires accurate and comprehensive
assessment of patients’ need in order to direct resources to those who need and can benefit from them the most.
Multimorbid patient selection is complicated due to the lack of clear criteria - unlike disease management
programs for which patients with a specific condition are identified. This ambiguity can potentially result in
inequitable selection, as biases in selection may differentially affect patients from disadvantaged population groups.
Patient selection could in principal be performed in three ways: physician referral, patient screening surveys, or by
statistical prediction algorithms. This paper discusses equity issues related to each method. We conclude that each
method may result in inequitable selection and bias, such as physicians’ attentiveness or familiarity, or prediction
models’ reliance on prior resource use, potentially affected by socio-cultural and economic barriers. These biases
should be acknowledged and dealt with. We recommend combining patient selection approaches to achieve high
care sensitivity, efficiency and equity.
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and future health care delivery: the growing diversity of
patient populations and the increasing burden of multiple
long term conditions. The majority of persons 65 and
older have multiple chronic conditions, and almost half
experience functional limitations associated with chronic
disease [1]. Multimorbidity (the co-occurrence of condi-
tions within individuals [2,3]), is consistently shown to be
associated with the large share of resource consumption
in various population groups and health care settings [4],
and with greater burden in minority and disadvantaged
populations [5].
Providing care for persons with multimorbidity re-
quires a shift from the prevailing single-disease biomed-
ical health care model, characterized by: lack of scientific
evidence on treatments for patients with multiple condi-
tions and deficiencies in teamwork, despite essential par-
ticipation of professionals from various specialties [6].* Correspondence: eshadmi@univ.haifa.ac.il
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distribution, and reproduction in any mediumPatients with multimorbidity report poor physician-
patient communication, worse interpersonal treatment,
and lack of care coordination [7,8]. To meet these chal-
lenges, care management programs are emerging, aiming
to provide better self management support and care co-
ordination [9,10].
The ability of multimorbid care management pro-
grams to meet the needs of their target population is, at
least in part, contingent on the way patients are selected
for entering such programs. Inclusion of patient who are
“too ill” and due to their overall morbidity might require
other types of care (for example, end of life care) or “too
healthy” and do not necessarily need intensive care man-
agement, will result in inefficiencies and possibly lack of
ability to show program effectiveness.
Patient selection – commonly called case finding –
could in principal be performed in three ways: i) physician
referral, ii) patient screening tools/Health Risk Assessment
(HRA), or iii) statistical prediction of future outcomes. Pri-
mary care physicians’ referral decisions are influenced by a
complex mix of patient, physician, and health care system
characteristics, with no standardized approach to referralCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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most common patient selection method, the lack of
standardization can lead to inefficiencies in the way pa-
tients are targeted for inclusion in resource intensive
programs. For example, in a “Get with the Guidelines”
study, referral of patients to a heart failure disease man-
agement program was examined [12]. The study showed
that referral was associated with atrial fibrillation,
implanted cardiac device, depression, and treatment at
larger hospitals. Yet, paradoxically, patients at higher
90-day mortality risk were less likely to be referred.
Patient screening tools provide a standardized ap-
proach for patient selection, based on the fulfillment of
specific criteria. An additional virtue of screening tools
is that they enable to incorporate information on pa-
tient characteristics with administrative and cost data
to assess overall risk. Information collected via screen-
ing surveys can elicit information which may not be
straightforwardly evident to the physician, whose refer-
ral is based mainly on clinical knowledge [13]. Similarly,
computerized predictive algorithms incorporate infor-
mation on various risk factors to provide a standard ap-
proach for selecting the highest risk patients [14]. Such
automated tools prevent the need for resource intensive
survey administration and can provide a-priori risk as-
sessments to large numbers of persons (patients or
health plan enrollees).
Patient selection tools are commonly used in clinical
practice for directing patients for receipt of appropriate
health care services, mostly for single disease or single
condition programs. Identification of patients for mul-
timorbidity care management provides additional chal-
lenges. First, the types of conditions considered and the
way multimorbidity is measured define the target popu-
lation for the program. Measuring multimoridity using
a limited set of conditions inevitably implies that selec-
tion is limited to patients with one or more conditions
from that list. Whether, for example, mental health
conditions and/or low prevalence conditions which
might be more common in specific population groups,
are considered, depends on these a-priori criteria. A
“whole-patient oriented” view of disease is more accur-
ate and equitable than an additive account of several
conditions. The greater likelihood of occurrence, sever-
ity, and adverse effects of health conditions within cer-
tain population groups is compounded even further by
multiple illnesses, multiple serious illnesses, and greater
likelihood of adverse events from incompatible inter-
ventions [15]. Thus, multimorbidity measures that ac-
count for the entire spectrum of health conditions,
interactions, severity and duration, provide a compre-
hensive classification of multimorbidity, which goes well
beyond the additive approach to stratification according
to a predetermined number of chronic conditions [16].Additionally, multimorbid case finding may be based on
a predetermined number and types of chronic conditions
either by physician referral and/or screening tools like
“Probability of Repeated Admissions” (Pra and Pra Plus)
[17] or “Identification of Seniors at Risk” (ISAR) [18]. Al-
ternatively, a number of statistical prediction models (PM),
based on diagnostic claims or Electronic Medical Record
(EMR) and resource use data, aim to identify patients
at highest risk for future high resource consumption
[14,19,20]. Research shows that such clinical PM models
provide better classification than PM that are based on
prior use alone [14,20,21].
Compared with physician referral, PM identify patients
at higher risk of healthcare utilization but with lower care
sensitivity, i.e. likelihood that preventive care will be suc-
cessful in these cases. Care sensitivity implies three key di-
mensions: patients’ willingness and ability to participate in
care management programs that are able to mitigate their
needs [22]. A review of alternative approaches to account
for patients’ ‘impactability’ revealed exclusion of highest-
risk cases, identification of care gaps and predicted risk of
disenrollment as current trends in case finding [23].
High-risk case identification and equity
High-risk case identification is intended to tailor resources
to patients who need them the most. While horizontal
equity aims to achieve equal distribution of resources, ver-
tical equity exists when people with greater needs are pro-
vided with greater resources [24]. Thus, targeting patients
for inclusion in resource intensive care management pro-
grams, may be viewed not only as an efficiency measure,
but also as a means to achieve greater vertical equity.
The attainment of equity, however, is contingent on the
type of high-risk case identification measure used. Ap-
proaches that fail to account for the entire spectrum of
morbidity may inaccurately reflect need [15], thus re-
sulting in inequitable selection. Moreover, when bias is in-
troduced into the case identification process, equity might
be jeopardized, as detailed below. We consider equity is-
sues related to patient selection via physician referrals, pa-
tient screening surveys, and automated PMs.
Physician identification for inclusion in care manage-
ment interventions follows the rational of any medical
referral, in which physicians/providers have the responsi-
bility and prerogative to refer patients to services and
treatments, according to need. Physicians have informa-
tion on the entire health and health related needs of pa-
tients, often not captured in clinical or administrative
databases [22,25,26]. Physicians are able to account for
patients’ care sensitivity thereby assisting resource allo-
cation to patients with highest likelihood to benefit from
preventive care. Physician referrals also overcome health
literacy and language proficiency barriers that may affect
patient selection via survey screening [27]. Moreover,
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of insurance claims or EMR data. Since PMs are based
on available diagnostic and resource use data, physician
referral may be more equitable as patients enrolled for a
short-term period may provide not enough data to be in-
cluded in PM. Moreover, accessibility, especially for the
use of specialty care and expensive imaging services may
be lower in marginalized populations, such as those of
low socioeconomic status [28,29], and result in an over-
all lower PM score. Additionally, PMs that are reliant on
pharmacy data may be affected by financial accessibility
[30], especially if data is derived from purchasing.
Another danger of PM tools is in the potential for mis-
use – PMs may impede access to care for most vulnerable
patients if using socioeconomic status as proxy for non-
compliance and therefore non-selection into intensive care
management [23]. Nonetheless, this type of non-selection
risk exists in all types of patient selection methods.
Patient selection according to physician referral how-
ever, is prone to several types of biases. Standardized ap-
proaches like PM and patient screening identify patients
based on objective criteria rather than relying on physi-
cians attentiveness [23] or personal attitudes [22]. PM
tools may identify gaps in (primary) care on an objective
basis [23]. In the case of high risk patients that do not
have a usual source of care, or have irregular use of health
care services, physicians’ knowledge of patient is poor and
the physician may not be able to accurately assess their
risk. Additionally, the fact that compared with PM physi-
cians tend to select patients with a prior history of partici-
pation in intensified care management programs [25]
suggests greater care sensitivity of physician referral but
may also indicate an “under the lamp-post” bias (i.e., pos-
sible bias towards non selection of those with lower adher-
ence or those with accessibility barriers).
Conclusion
Active selection of eligible patients for multimorbidity
care management is an equity issue. Each of the different
case finding approaches provides opportunities for both
increasing and decreasing equity in healthcare. Benefits
of objective criteria for case finding in PM for example,
may at least partly be outweighed by data inputs needs or
‘inequitable’ modeling algorithms. Conversely, physicians
may be prone to select their more engaging patients for in-
clusion in intensive care management, overlooking patients
with complex care needs with a history of lower care en-
gagement which may be due to socio-cultural barriers to
care. Therefore, health care providers and health author-
ities should be aware of equity issues whenever selecting
multimorbid patients for tailored care management as any
selection method principally comes along with not-
selecting others, who may be in need of intensified care
services. When non-selected patients are more likely tocome from disadvantaged population groups (as demon-
strated by the “inverse care” law [31]) equity is jeopardized.
Current trends in predictive modeling like the introduction
of models which incorporate proxies for care sensitivity
may or may not increase equity depending on how proxies
like socioeconomic status are used (see above).
To conclude, this overview of equity in multimorbid
patient selection approaches suggests that combining
different case finding approaches like PM and physician
referral may help to overcome the pitfalls of each of the
two [22,25]. Although rigorous studies comparing the
effect of case finding on equity are lacking to date, first
attempts show promising results [10].
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